Enriched cereal bars are more effective in increasing plasma quercetin compared with quercetin from powder-filled hard capsules

British Journal of Nutrition

Volumn 107, Issue 4, 2012, Pages 539-546

  Egert, Sarah ^a,b   Wolffram, Siegfried ^b   Schulze, Beate ^b   Langguth, Peter ^c   Hubbermann, Eva Maria ^b   Schwarz, Karin ^b   Adolphi, Berit ^d   Bosy Westphal, Anja ^b   Rimbach, Gerald ^b   Müller, Manfred James ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d Schwartauer Werke GmbH and CoKGaA   (Germany)

Author keywords

Bioavailability; Human studies; Onions; Quercetin

Indexed keywords

4' O METHYLQUERCETIN; FLAVONOID; ISORHAMNETIN; PLACEBO; PLANT MEDICINAL PRODUCT; QUERCETIN; QUERCETIN 4' GLUCOSIDE; QUERCETIN AGLYCONE; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CEREAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DETERMINATION; DRUG PURITY; FEMALE; FLUORESCENCE ANALYSIS; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; POWDER; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADULT; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; CAPSULES; CEREALS; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DISACCHARIDES; FAST FOODS; FEMALE; FOOD, FORTIFIED; HUMANS; KINETICS; NUTRITIVE VALUE; PILOT PROJECTS; POWDERS; QUERCETIN; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 84863399512     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511003242     Document Type: Article

References (34)

1. Erdman JW Jr, Balentine D, Arab L, et al. (2007) Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC. J Nutr 137, 718S-737S. (Pubitemid 46397511)
2. Graf BA, Milbury PE & Blumberg JB (2005) Flavonols, flavones, flavanones, and human health: Epidemiological evidence. J Med Food 8, 281-290. (Pubitemid 41502409)
3. Manach C, Williamson G, Morand C, et al. (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81, 230S-242S.
4. Scalbert A & Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130, 2073S-2085S. (Pubitemid 30619386)
5. Harwood M, Danielewska-Nikiel B, Borzelleca JF, et al. (2007) A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol 45, 2179-2205. (Pubitemid 47451573)
6. Olthof MR, Hollman PC, Vree TB, et al. (2000) Bioavailabilities of quercetin-3-glucoside and quercetin-40-glucoside do not differ in humans. J Nutr 130, 1200-1203. (Pubitemid 30233268)
7. Hollman PC, de Vries JH, van Leeuwen SD, et al. (1995) Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 62, 1276-1282.
8. Wiczkowski W, Romaszko J, Bucinski A, et al. (2008) Quercetin from shallots (Allium cepa L. var. aggregatum) is more bioavailable than its glucosides. J Nutr 138, 885-888. (Pubitemid 351571587)
9. Egert S, Bosy-Westphal A, Seiberl J, et al. (2009) Quercetin reduces systolic blood pressure and plasma oxidized low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: A double-blinded, placebo-controlled cross-over study. Br J Nutr 102, 1065-1074.
10. Egert S, Boesch-Saadatmandi C, Wolffram S, et al. (2010) Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. J Nutr 140, 278-284.
11. Bosy-Westphal A, Danielzik S, Becker C, et al. (2005) Need for optimal body composition data analysis using airdisplacement plethysmography in children and adolescents. J Nutr 135, 2257-2262. (Pubitemid 41298397)
12. Bieger J, Cermak R, Blank R, et al. (2008) Tissue distribution of quercetin in pigs after long-term dietary supplementation. J Nutr 138, 1417-1420.
13. Linseisen J, Radtke J & Wolfram G (1997) Flavonoidzufuhr Erwachsener in einem bayrischen Teilkollektiv der Nationalen Verzehrsstudie (Flavonoid intake of adults in a Bavarian subgroup of the National Nutrition Survey). Z Ernahrungswiss 36, 403-412. (Pubitemid 28026863)
14. Böhm H, Boeing H, Hempel J, et al. (1998) Flavonols, flavone and anthocyanins as natural antioxidants of food and their possible role in the prevention of chronic diseases. Z Ernahrungswiss 37, 147-163. (Pubitemid 28318357)
15. Egert S, Wolffram S, Bosy-Westphal A, et al. (2008) Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 138, 1615-1621.
16. Boyle SP, Dobson VL, Duthie SJ, et al. (2000) Absorption and DNA protective effects of flavonoid glycosides from an onion meal. Eur J Nutr 39, 213-223.
17. Graefe EU, Wittig J, Mueller S, et al. (2001) Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 41, 492-499. (Pubitemid 32381866)
18. Moon YJ, Wang L, Dicenzo R, et al. (2008) Quercetin pharmacokinetics in humans. Biopharm Drug Dispos 29, 205-217. (Pubitemid 351802843)
19. Williamson G & Manach C.2005) Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81, 243S-255S.
20. Manach C, Scalbert A, Morand C, et al. (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79, 727-747. (Pubitemid 41103873)
21. Piskula MK & Terao J.1998) Quercetin's solubility affects its accumulation in rat plasma after oral administration. J Agric Food Chem 46, 4313-4317. (Pubitemid 128488535)
22. Sri KV, Kondaiah A, Ratna JV, et al. (2007) Preparation and characterization of quercetin and rutin cyclodextrin inclusion complexes. Drug Dev Ind Pharm 33, 245-253. (Pubitemid 46650742)
23. Azuma K, Ippoushi K, Ito H, et al. (2002) Combination of lipids and emulsifiers enhances the absorption of orally administered quercetin in rats. J Agric Food Chem 50, 1706-1712. (Pubitemid 34233251)
24. Lesser S, Cermak R & Wolffram S (2004) Bioavailability of quercetin in pigs is influenced by the dietary fat content. J Nutr 134, 1508-1511. (Pubitemid 38720730)
25. Lesser S, Cermak R & Wolffram S (2006) The fatty acid pattern of dietary fat influences the oral bioavailability of the flavonol quercetin in pigs. Br J Nutr 96, 1047-1052. (Pubitemid 46470167)
26. Krishnaiah YSR (2010) Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs. J Bioequiv Bioavail 2, 28-36.
27. Ader P, Wessmann A & Wolffram S (2000) Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic Biol Med 28, 1056-1067. (Pubitemid 30314704)
28. Cermak R, Landgraf S & Wolffram S (2003) The bioavailability of quercetin in pigs depends on the glycoside moiety and on dietary factors. J Nutr 133, 2802-2807. (Pubitemid 37099763)
29. Boesch-Saadatmandi C, Egert S, Schrader C, et al. (2010) Effect of quercetin on paraoxonase 1 activity-studies in cultured cells, mice and humans. J Physiol Pharmacol 61, 99-105.
30. Boesch-Saadatmandi C, Wolffram S, Minihane AM, et al. (2009) Effect of apoE genotype and dietary quercetin on blood lipids and TNF-alpha levels in apoE3 and apoE4 targeted gene replacement mice. Br J Nutr 101, 1440-1443.
31. de Boer VC, Dihal AA, van der WH, et al. (2005) Tissue distribution of quercetin in rats and pigs. J Nutr 135, 1718-1725. (Pubitemid 40980724)
32. Boesch-Saadatmandi C, Loboda A, Wagner AE, et al. (2010) Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: Role of miR-155. J Nutr Biochem 22, 293-299.
33. Zhu BT, Ezell EL & Liehr JG (1994) Catechol-O-methyltransferase- catalyzed rapid O-methylation of mutagenic flavonoids. Metabolic inactivation as a possible reason for their lack of carcinogenicity in vivo. J Biol Chem 269, 292-299.
34. Kottra G & Daniel H (2007) Flavonoid glycosides are not transported by the human Nap/glucose transporter when expressed in Xenopus laevis oocytes, but effectively inhibit electrogenic glucose uptake. J Pharmacol Exp Ther 322, 829-835. (Pubitemid 47105799)